Decreased Th17 cell numbers in favor of enhanced proportions of regulatory T cells, accompanied by reduced lymphocyte IL-17A secretion and disease severity reduction, were also detected after EGCG treatment in murine models of autoimmune encephalomyelitis, arthritis, colitis, and obesity [59,71,72,73,74]. This evidence concerns the gene IL17A and arthritic joint disease.